The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery

BackgroundMyosteatosis is a well-established predictor of poor prognosis in many types of cancer, and a decreased Creatinine/Cystatin C ratio (CCR) is a known indicator of unfavorable outcomes in patients with metabolic disorders and cancer. Despite this knowledge, the significance of concurrent CCR...

Full description

Bibliographic Details
Main Authors:	Yan Liu, Jingli Zhang, Guanghui Song, Xueli Ding, Hui Sun, Jianrui Zhou, Xue Jing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Oncology
Subjects:	cholangiocarcinoma myosteatosis creatinine/cystatin c ratio radical excision prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1233768/full

Similar Items

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

Diagnostic Value of Cystatin C and Creatinine Detection in Blood Serum of Newborns at Ischemic Nephropathy
by: A.M. Loboda, et al.
Published: (2012-02-01)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
by: Shanshan Shi, et al.
Published: (2022-08-01)

Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
by: Leonor Bardallo Cruzado, et al.
Published: (2015-05-01)

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
by: Hamid Eshraghi, et al.
Published: (2009-06-01)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
by: Markus S. Jördens, et al.
Published: (2021-09-01)

Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
by: Yueli Zhu, et al.
Published: (2022-09-01)

Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury
by: Kamel A. Gharaibeh, et al.
Published: (2018-03-01)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
by: Chan‐Young Jung, et al.
Published: (2022-08-01)

Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults
by: Chiu-Shong Liu, et al.
Published: (2020-10-01)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
by: Mariko Tsukagoshi, et al.
Published: (2023-09-01)

Estimation of glomerular filtration rate from serum cystatin C and creatinine in patients with thyroid dysfunction
by: Čabarkapa Velibor, et al.
Published: (2012-01-01)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
by: Jung Nam An, et al.
Published: (2022-09-01)

Predictive value of serum creatinine/cystatin C in neurocritically ill patients
by: Shengnan Wang, et al.
Published: (2019-12-01)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
by: Liming Ding, et al.
Published: (2023-06-01)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
by: Yu-Li Lin, et al.
Published: (2022-02-01)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
by: Ichiro Yoshii, et al.
Published: (2023-05-01)

Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients
by: Sichao Chen, et al.
Published: (2021-03-01)

Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFRPlain-Language Summary
by: Yeli Wang, et al.
Published: (2023-10-01)

Glomerular filtration rate determination by creatinine and cystatin-C in patients with acute pyelonephritis
by: Hadi Sorkhi, et al.
Published: (2018-05-01)

Estimating eGFR using Serum Cystatin C alone and in combination with Serum Creatinine: A Prospective study in individuals with CKD in north Telangana
by: B Venugopal1 , S Sangeeta2
Published: (2018-08-01)

The Inter-Trimester Variation and Prognostic Value of Creatinine, Cystatin C and Uric Acid in Preeclamptic Patients: A Retrospective Study
by: Junpeng Jing, et al.
Published: (2023-02-01)

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
by: Ren C, et al.
Published: (2022-03-01)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
by: Anders O. Larsson, et al.
Published: (2022-10-01)

Serum Cystatin C as a Potential Marker for Glomerular Filtration Rate in Patients with Cholangiocarcinoma
by: Mang Ngaih Ciin, et al.
Published: (2020-07-01)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
by: Shunhui Gao, et al.
Published: (2023-06-01)

Comparison of Creatinine and Cystatin C to Estimate Renal Function in Geriatric and Frail Patients
by: Erik Dahlén, et al.
Published: (2022-06-01)

Diagnostic importance of cystatin C and creatinine for contrast-induced acute kidney injury
by: Pilčević Dejan, et al.
Published: (2021-01-01)

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
by: Wen-He Zheng, et al.
Published: (2023-01-01)

Impact of cystatin C-derived glomerular filtration rate in patients undergoing transcatheter aortic valve implantation
by: Yusuke Kure, et al.
Published: (2023-04-01)

Estimation of the glomerular filtration rate – comparison between serum creatinine, cystatin c and calculated creatinine clearance
by: Radovan Hojs, et al.
Published: (2006-08-01)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
by: Stéphanie Leroux, et al.
Published: (2021-03-01)

Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
by: Debbie C. Chen, et al.
Published: (2024-04-01)

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01)

Estimated glomerular filtration rate by serum creatinine or standardized cystatin C in Japanese patients with Graves׳ disease
by: Yoshitake Suzuki, et al.
Published: (2015-12-01)

Cystatin C and uncontrolled hypertension
by: Mehmet Onur Omaygenç, et al.
Published: (2020-10-01)

Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort
by: T. D. K. S. C. Gunasekara, et al.
Published: (2023-12-01)

Is the Chronic Kidney Disease Epidemiology Collaboration creatinine–cystatin C equation useful for glomerular filtration rate estimation in the elderly?
by: Liu X, et al.
Published: (2013-10-01)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
by: Young Youl Hyun, et al.
Published: (2022-09-01)